The effect of unfractionated heparin on thrombelastographic analysis in healthy dogs

被引:27
作者
Pittman, Jennifer R. [1 ]
Koenig, Amie [1 ]
Brainard, Benjamin M. [1 ]
机构
[1] Univ Georgia, Coll Vet Med, Dept Small Anim Med & Surg, Athens, GA 30602 USA
关键词
coagulation; monitoring; TEG; thromboelastograph; thromboelastography; DISSEMINATED INTRAVASCULAR COAGULATION; PARTIAL THROMBOPLASTIN TIME; THROMBIN GENERATION; HYPERCOAGULABILITY; ASSAY;
D O I
10.1111/j.1476-4431.2010.00519.x
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Objective To determine the effect of single and multiple doses of SQ heparin (200 U/kg) on the thrombelastogram of healthy dogs. Design Prospective study. Setting University research facility. Animals Six random-source female dogs. Interventions Baseline parameters, including a CBC with platelet count, prothrombin time, activated partial thromboplastin time (aPTT), and antithrombin were performed. Thrombelastography (TEG) and aPTT were performed hourly for 12 hours after unfractionated heparin dosing (200 U/kg, SQ). Anti-Xa activity was assayed at 0, 3, 6, and 8 hours. Heparin was then administered every 8 hours for 3 days. The sampling protocol on Day 4 was identical to Day 1. Measurements and Main Results On Day 1, percentage change from baseline for TEG parameter R, as well as absolute values of K, angle, and maximum amplitude (MA) were evaluated. Statistically significant (P < 0.01) prolongation of the R time and a decrease in angle and MA was seen in all dogs by hour 3. R and MA were unmeasurable for most dogs between 3 and 5 hours. All TEG tracings returned to baseline by 12 hours. Day 4 TEG tracings mimicked those on Day 1. Only 1 dog achieved aPTT values outside the reference interval on both days. Anti-Xa activity levels increased on Day 4 but not on Day 1. Based on post hoc in vitro analysis, prolongation of R time occurred at plasma heparin levels as low as 0.075 U/mL, well below the lower limit of detection of the anti-Xa activity level assay. Conclusions Administration of SQ heparin results in progressive changes in the TEG tracing, with maximal change occurring 3-5 hours after dosing. The extensive prolongation of the R time also indicates that TEG may be too sensitive and limits its utility as a monitoring tool for unfractionated heparin therapy.
引用
收藏
页码:216 / 223
页数:8
相关论文
共 30 条
[1]  
Alwood AJ, 2007, J VET INTERN MED, V21, P378, DOI 10.1892/0891-6640(2007)21[378:AEOLHI]2.0.CO
[2]  
2
[3]   Thrombin generation after the abrupt cessation of intravenous unfractionated heparin among patients with acute coronary syndromes - Potential mechanisms for heightened prothrombotic potential [J].
Becker, RC ;
Spencer, FA ;
Li, YF ;
Ball, SP ;
Ma, YS ;
Hurley, T ;
Hebert, J .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (04) :1020-1027
[4]   Rebound thrombin generation after heparin therapy in unstable angina -: A Randomized comparison between unfractionated and low-molecular-weight heparin [J].
Bijsterveld, NR ;
Moons, AH ;
Meijers, JCM ;
Tijssen, JGP ;
Büller, HR ;
Levi, M ;
Peters, RJG .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) :811-817
[5]  
Brooks M., 2000, Textbook of veterinary internal medicine: diseases of the dog and cat, Volumes 1 and 2., P1829
[6]   Evaluation of a chromogenic assay to measure the factor Xa inhibitory activity of unfractionated heparin in canine plasma [J].
Brooks, MB .
VETERINARY CLINICAL PATHOLOGY, 2004, 33 (04) :208-214
[7]  
Chandler WL, 1995, SEMIN THROMB HEMOST, V21, P1
[8]  
Couto CG, 1999, VET MED-US, V94, P547
[9]   Effects of clopidogrel on the rebound hypercoagulable state after heparin discontinuation in patients with acute coronary syndromes [J].
Di Nisio, M ;
Bijsterveld, NR ;
Meijers, JCM ;
Levi, M ;
Büller, HR ;
Peters, RJG .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (08) :1582-1583
[10]   Pharmacokinetics and pharmacodynamics of a therapeutic dose of unfractionated heparin (200 U/kg) administered subcutaneously or intravenously to healthy dogs [J].
Diquélou, A ;
Barbaste, C ;
Gabaig, AM ;
Trumel, C ;
Abella-Bourges, N ;
Guelfi, JF ;
Mélou, AB .
VETERINARY CLINICAL PATHOLOGY, 2005, 34 (03) :237-242